Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-24-011339
Filing Date
2024-08-30
Accepted
2024-08-30 16:19:27
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tenx_s3.htm S-3 265225
2 OPINION OF WYRICK ROBBINS tenx_ex51.htm EX-5.1 9591
3 CONSENT OF CHERRY BEKAERT LLP tenx_ex231.htm EX-23.1 2233
4 FILING FEE TABLE tenx_ex107.htm EX-FILING FEES 23424
5 tenx_s3img1.jpg GRAPHIC 4512
6 tenx_s3img2.jpg GRAPHIC 4512
  Complete submission text file 0001654954-24-011339.txt   314495
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281873 | Film No.: 241270347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)